Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4342-4348

  Akbulut, D ^a   Grant, K A ^a   McLauchlin, J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; NEUROTOXIN;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOASSAY; BOTULISM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; DNA EXTRACTION; GENE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TETANUS; UNITED KINGDOM; WOUND INFECTION;

ANIMALS; BOTULINUM TOXINS; BOTULISM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; HUMANS; METALLOENDOPEPTIDASES; MICE; POLYMERASE CHAIN REACTION; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; TETANUS; TETANUS TOXIN; WOUND INFECTION;

ANIMALIA; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI;

EID: 24744454624     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4342-4348.2005     Document Type: Article

References (34)

1. Akbulut, D., K. A. Grant, and J. McLauchlin. 2004. Application and development of real-time PCR assays to detect fragments of the Clostridium botulinum types A, B, and E neurotoxin genes for investigation of human food-borne and infant botulism. Foodborne Pathogen Dis. 1:247-257.
2. Anonymous. 1971. Immunoserum antitetanicum, tetanus antitoxin. Eur. Pharmocopoeia II:274-278.
3. Anonymous. 1988. Biological assay of Clostridium tetani antitoxin, p. A116-A117. Appendix XIVB. British Pharmocopoeia, HMSO, London, United Kingdom.
4. Anonymous. 1997. Case definitions for infectious conditions under public health surveillance. Morb. Mortal. Weekly Rep. 46:RR101-RR155.
5. Anonymous. 1998. Botulism in the United States, 1899-1996: handbook for epidemiologists, clinicians, and laboratory workers. Centers for Disease Control and Prevention, Atlanta, Ga.
6. Anonymous. 2003. Clostridium botulinum. [Online.], http://www.sanger.ac. uk/Projects/C_botulinum/.
7. Brazier, J. S., M. Gal, V. Hall, and T. E. Morris. 2004. Outbreak of Clostridium histolyticum infections amongst drug users in England and Scotland. Eur. Surveillance 9:15-16.
8. Brett, M. M., G. Hallas, and O. Mpamugo. 2004. Wound botulism in the UK and Ireland. J. Med. Microbiol. 53:555-561.
9. Brett, M. M., J. McLauchlin, A. Harris, S. O'Brien, N. Black, D. Roberts, and F. J. Bolton. 2005. A case of infant botulism with a possible link to infant formula milk powder: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food. J. Med. Microbiol. 54:769-776.
10. Bruggemann, H., S. Baumer, W. F. Fricke, A. Wiezer, H. Liesegang, I. Decker, C. Herzberg, R. Martinez-Arias, R. Merkl, A. Henne, and G. Gottschalk. 2003. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc. Natl. Acad. Sci. USA 100:1316-1321.
11. Collins, M. D., and A. K. East. 1998. Phylogeny and taxonomy of the foodborne pathogen Clostridium botulinum and its neurotoxins. J. Appl. Microbiol. 84:5-17.
12. Dancer, S. J., D. McNair, P. Finn, and A. B. Kolsto. 2002. Bacillus census cellulitis from contaminated heroin. J. Med. Microbiol. 51:278-281.
13. Dezfulian, M., L. M. McCroskey, C. L. Hatheway, and V. R. Dowell. 1981. Selective medium for isolation of Clostridium botulinum from human feces. J. Clin. Microbiol. 13:526-531.
14. Feltham, R. K., A. K. Power, P. A. Pell, and P. A. Sneath. 1978. A simple method for storage of bacteria at -76°C. J. Appl. Bacteriol. 44:313-316.
15. Ferreira, J. L., S. Maslanka, E. Johnson, and M. Goodnough. 2003. Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study. J. AOAC Int. 86:314-331.
16. Hahne, S., N. Crowcroft, J. White, F. Ncube, V. Hope, L. de Souza, M. Brett, K. Roy, and D. Goldberg. 2004. Ongoing outbreak of tetanus in injecting drug users in the UK. Eur. Surveillance 9:40-41.
17. Hatheway, C. L. 1990. Toxigenic clostridia. Clin. Microbiol. Rev. 3:66-98.
18. Hatheway, C. L., and E. A. Johnson. 1998. Clostridium: the spore bearing anaerobes, p. 731-782. In A. Balows, and B. I. Duerden (ed.), Topley and Wilson's microbiology and microbial infections, 9th ed. Arnold, London, United Kingdom.
19. Hatheway, C. L., and L. M. McCroskey. 1987. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J. Clin. Microbiol. 25:2334-2338.
20. Hielm, S., J. Bjorkroth, E. Hyytia, and H. Korkeala. 1998. Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 64:703-708.
21. Hope, V., F. Ncube, J. Dennis, and J. McLauchlin. 2004. Wound botulism: increase in cases in injecting drug users, United Kingdom. Eur. Surveillance 9:39-40.
22. Lalli, G., S. Bohnert, K. Deinhardt, C. Verastegui, and G. Schiavo. 2003. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol. 11:431-437.
23. McGiuggan, C. C., G. M. Penrice, L. Gruer, S. Ahmed, D. Goldberg, M. Black, J. E. Salmon, and J. Hood. 2002. Lethal outbreak of infection with Clostridium novyi type A and other spore forming organisms in Scottish injecting drug users. J. Med. Microbiol. 51:971-977.
24. McLauchlin, J., S. Pedraza-Díaz, C. Amar-Hoetzeneder, and G. L. Nichols. 1999. Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis. J. Clin. Microbiol. 37:3153-3158.
25. Mills, D. C., T. F. Midura, and S. S. Aron. 1985. Improved selective medium for the isolation of lipase positive Clostridium botulinum from feces of human infants. J. Clin. Microbiol. 21:947-950.
26. Peruski, A. H., L. H. Johnson, and L. F. Peruski. 2002. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence as-says. J. Immunol. Methods 263:35-41.
27. Poli, M. A., V. R. Rivera, and D. Neal. 2002. Development of sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F. Toxicon 40:797-802.
28. Schoener, E. P., J. A. Hopper, and J. D. Pierre. 2002. Injection drug use in North America. Infect. Dis. Clin. N. Am. 16:535-551.
29. Solomon, H. M., and T. Lilly. 2001. Clostridium botulinum. FDA bacteriological analytical manual online, 8th ed., revision A, 1998. [Online.] http://www.cfsan.fda.gov/~ebam/bam-17.html#authors.
30. Van Baar, B. L., A. G. Hulst, A. L. de Jong, and E. R. Wils. 2002. Characterization of botulinum toxins type A and B, by matrix-assisted laser desorption ionization and electrospray mass spectrometry. J. Chromatogr. A. 970:95-115.
31. Van Baar, B. L., A. G. Hulst, A. L. de Jong, and E. R. Wils. 2004. Characterization of botulinum toxins type C, D, E, and F by matrix-assisted laser desorption ionization and electrospray mass spectrometry. J. Chromatogr. A 1035:97-114.
32. Weber, J. T., H. C. Goodpasture, H. Alexander, S. B. Werner, C. L. Hatheway, and R. V. Tauxe. 1993. Wound botulism in a patient with a tooth abscess: case report and review. Clin. Infect. Dis. 16:635-039.
33. Werner, S. B., D. Passaro, J. McGee, R. Schechter, and D. J. Vugia. 2000. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin. Infect. Dis. 31:1018-1024.
34. Wictome, M., K. Newton, K. Jameson, B. Hallis, P. Dunnigan, E. Mackay, S. Clarke, R. Taylor, J. Gaze, K. Foster, and C. Shone. 1999. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay. Appl. Environ. Microbiol. 65:3787-3792.